Background: Extra-axial chordomas are rare low-grade malignant tumors thought to arise from notochordal remnants in the extra-axial skeleton. Few studies have been done on this neoplasm because of its rarity. In addition, there is a lack of a good in vitro model on which to perform more characterization.

Methods: We describe a twenty-eight-year-old man with a mass in the right scapula. Cytomorphology and immunohistochemistry, including brachyury staining, were used to formulate the final diagnosis. A fragment of the tumor was placed in culture, and cells obtained were injected subcutaneously in an immunocompromised mouse. From the tumor developed in mice, a cell line has been derived and characterized by fluorescence-activated cell-sorting analysis, karyotyping, clonogenicity, and cell and tumor growth curves.

Results: Cytomorphology on the tumor showed nests of round cells with vacuoles and also physaliferous-like cells with uniform nuclei. Immunochemistry revealed a tumor positive for vimentin, moderately positive for S-100 and cytokeratin AE1/AE3, weakly positive for epithelial membrane antigen, and negative for p63 and cytokeratin (CK)-7. Further analysis revealed the tumor was diffusely and strongly positive for brachyury. The cell line derived from the tumor showed rapid doubling-time, a strong expression of mesenchymal cell surface markers, a karyotype of diploid or hypotetraploid clones with numerous chromosomal aberrations, and the ability to form colonies without attachment and to form tumors in immunocompromised mice.

Conclusions: The diagnosis of the extra-axial chordoma is difficult but can be resolved by the detection of a strong brachyury expression. In addition, the derivation of a human extra-axial chordoma cell line could be a useful tool for the basic research of this rare neoplasm.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000130PMC
http://dx.doi.org/10.2106/JBJS.I.00594DOI Listing

Publication Analysis

Top Keywords

extra-axial chordoma
12
chordoma cell
8
tumor
8
cell derived
8
revealed tumor
8
cell
6
extra-axial
5
derivation characterization
4
characterization extra-axial
4
cell each-1
4

Similar Publications

Article Synopsis
  • Poorly differentiated chordoma is a rare and aggressive type of tumor usually found in young patients, mainly at the skull base and cervical spine.
  • A case study of a 60-year-old patient initially misdiagnosed with osteoarthritis revealed complex tumor characteristics that led to reconsideration of its diagnosis.
  • The importance of accurate immunohistochemical testing, specifically for brachyury, is emphasized for correctly diagnosing this uncommon tumor and for understanding its unique molecular profile, which could aid in future analyses.
View Article and Find Full Text PDF

Background: Chordomas are primary bone tumors derived from the embryonic notochord. They represent 1-4% of all malignant bone tumors. They have a predominantly extra-axial location, arising in the clival region in 35% of reported cases.

View Article and Find Full Text PDF
Article Synopsis
  • Chordoma is a rare malignant tumor usually found in young patients, typically affecting the axial skeleton; this report focuses on a case involving a 74-year-old male with a high-grade tumor in the knee.
  • Initial biopsies suggested metastatic clear-cell carcinoma, but imaging studies didn’t identify any primary tumors, leading to further investigation.
  • Advanced molecular genetic analysis, including methylation profiling, identified the tumor as poorly differentiated chordoma, highlighting the importance of using comprehensive diagnostic tools for rare soft tissue tumors.
View Article and Find Full Text PDF

Chordomas are rare, locally aggressive, primary bone tumors derived from primitive notochord remnants. They almost always arise within the axial skeleton, particularly in the skull base and the sacrococcygeal region. They usually present as extradural tumors, but rarely, they present as entirely intradural tumors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!